Arcadia Biosciences, Inc. 4
4 · Arcadia Biosciences, Inc. · Filed Feb 3, 2016
Insider Transaction Report
Form 4
Rey Eric J.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2016-02-01$2.93/sh−3,000$8,794→ 140,380 total - Sale
Common Stock
2016-02-03$2.78/sh−200$556→ 140,180 total
Footnotes (3)
- [F1]The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 Stock Trading Plan adopted by the Reporting Person effective December 14, 2015.
- [F2]This transaction was executed in multiple trades at prices ranging from $2.80 to $3.05. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]Includes 750 shares acquired under the Issuer's 2015 Employee Stock Purchase Plan on February 1, 2016.